InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,010.60
(
0.87%
)
US TECH 100
16,808.80
(
0.33%
)
Dow Jones
38,239.98
(
0.00%
)
Brent Oil
85.68
(
-0.85%
)
Bitcoin
66,036.22
(
-1.23%
)
Post# of 251565
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

NY1972

Send PM Follow Ignore
Followers 4
Posts 1194
Boards Moderated 0
Alias Born 10/03/2015

NY1972

Re: dewophile post# 210739

Sunday, 04/23/2017 11:49:12 AM

Sunday, April 23, 2017 11:49:12 AM

Post# of 251565
Blincyto also showed greatest effect in low tumor burden, peaking in explicit MRD. I wonder if Amgen is interested to try a CD47 + CD3 combo, TTI621 + Blincyto in ALL.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up